Quick Facts
| Legal Status | Medical Since | Adult Use | Access Type | Est. Monthly Cost | Insurance |
|---|---|---|---|---|---|
| Medical — Pilot Programme (2023) | 2023 (pilot) / Sativex since 2012 | No (pilot trial ongoing) | Specialist prescription via cantonal health department | CHF 200–CHF 600/month | No (Krankenkasse does not cover) |
Legal Timeline
| Year | Development |
|---|---|
| 2012 | Sativex approved for MS — first legal cannabis medicine in Switzerland |
| 2021 | Federal Council approves scientific pilot trial framework |
| 2022 | Swiss cities (Basel, Zurich, Geneva, Bern) approved for pilot trials |
| 2023 | Pilots launch — residents can purchase cannabis from authorised outlets |
| 2024 | Data collection ongoing; results expected to inform legislation by 2026 |
How to Access Medical Cannabis in Switzerland
- Check if you live in a city running an active pilot trial (Zürich, Basel, Geneva, Bern, Lausanne, others)
- Register for the pilot through your cantonal health department or pilot operator
- For medical access outside pilots: consult a specialist and apply for an exceptional authorisation from Swissmedic
- Sativex (MS only) is prescribable by any neurologist without exceptional authorisation
- Pilot participants purchase cannabis at authorised pharmacies or social clubs within the pilot
Qualifying Conditions
- Multiple sclerosis spasticity (Sativex)
- Chronic pain (pilot)
- Anxiety (pilot)
- Sleep disorders (pilot)
- General adult use (pilot — non-medical)
Licensed Providers & Clinics
| Provider | Website | Notes |
|---|---|---|
| Swissmedic | swissmedic.ch | Swiss national medicines authority — issues exceptional authorisations |
| ZüriCan (Zürich pilot) | Zürich city pilot programme operator | |
| Paracelsus Today | Basel pilot programme operator | |
| Swiss Cannabis Clinics | Specialist clinics supporting medical access applications |
Cost Breakdown
| Item | Estimated Cost (CHF) | Insurance Coverage |
|---|---|---|
| Pilot purchase (monthly) | CHF 100–CHF 300 | Not covered by Krankenkasse |
| Sativex (MS, per bottle) | CHF 200–CHF 350 | May be covered for MS |
| Swissmedic exceptional auth. | CHF 200–CHF 500 (process fee) | Not covered |
| Specialist consultation | CHF 150–CHF 350 | Covered by Krankenkasse if in-network |
Frequently Asked Questions
Is cannabis legal in Switzerland?+
Switzerland is running official government pilot trials in multiple cities since 2022–2023. Participants in these pilots can legally purchase cannabis from authorised outlets. Outside the pilots, only Sativex (for MS) is legally prescribable. Recreational use remains illegal.
How do I join a Swiss cannabis pilot?+
Pilots are city-specific. You must be a registered resident of the pilot city, be 18 or older, and register through the official pilot operator. Trials have participant caps. Check the cantonal health department of your city (Zürich: ZüriCan; Basel: Paracelsus Today; Geneva: SCRIPT).
Can I get medical cannabis in Switzerland without a pilot?+
Outside pilots, you need a Swissmedic exceptional authorisation for any non-Sativex cannabis medicine. This process is complex and time-consuming. Sativex remains the easiest legal option for MS spasticity without exceptional authorisation.
Does Swiss health insurance cover medical cannabis?+
Krankenkasse (basic mandatory health insurance) does not cover cannabis-based medicines except potentially Sativex for MS in some cases. Pilot programme costs are fully out of pocket for participants.
What will happen after the Swiss pilots end?+
The federal government will use pilot data to inform potential legalisation legislation. A vote on broader cannabis regulation is anticipated in the coming years, consistent with Swiss direct democracy practice.
Is CBD legal in Switzerland?+
Yes — Switzerland has one of the most permissive CBD frameworks in Europe. CBD products with up to 1% THC are legal to sell, which is higher than the EU's 0.2% limit. CBD flowers and products are widely available in shops and pharmacies.